OncoVerity

Aurora, Colorado, United States

OncoVerity is a mission-driven healthcare startup focused on transforming cancer treatment through the application of computational tools to clinical and biological data. The company, comprised of experienced professionals from various sectors including academia, the clinic, and industry, recognizes the complexity of cancer as a multifaceted disease that affects individuals differently. They aim to develop therapies that instill hope and improve outcomes for cancer patients. Their current research includes clinical trials, such as evaluating Cusatuzumab combined with azacitidine for patients with newly diagnosed acute myeloid leukemia (AML) and investigating the interactions of nasopharyngeal carcinoma cells that affect regulatory T cell development.